Litcius/Paper detail

Effective treatment of locally advanced periocular basal cell carcinoma with oral hedgehog pathway inhibitor?

Xiaoyi Hou, Alexander C. Rokohl, Monika Ortmann, Ludwig M. Heindl

2020Graefe s Archive for Clinical and Experimental Ophthalmology25 citationsDOIOpen Access PDF

Abstract

Purpose!#!To assess corneal stiffening of standard (S-CXL) and accelerated (A-CXL) cross-linking protocols by dynamic corneal response parameters and corneal bending stiffness (Kc[mean/linear]) derived from Corvis (CVS) Scheimpflug-based tonometry. These investigations were validated by corneal tensile stiffness (K[ts]), derived from stress-strain extensometry in ex vivo porcine eyes.!##!Methods!#!Seventy-two fresh-enucleated and de-epithelized porcine eyes were soaked in 0.1% riboflavin solution including 10% dextran for 10 min. The eyes were separated into four groups: controls (n = 18), S-CXL (intensity in mW/cm!##!Results!#!In CVS, biomechanical effects of cross-linking were shown to have a significantly decreased deflection amplitude as well as integrated radius, an increased IOP, and SP A1 (P < 0.05). Kc[mean]/Kc[linear] were significantly increased after CXL (P < 0.05). In the range from 2 to 6% strain, K[ts] was significantly higher in S-CXL (3*30) compared to A-CXL (9*10), A-CXL (18*5), and controls (P < 0.05). At 8% to 10% strain, all protocols induced a higher stiffness than controls (P < 0.05).!##!Conclusion!#!Several CVS parameters and Kc[mean] as well as Kc[linear] verify corneal stiffening effect after CXL on porcine eyes. S-CXL seems to have a higher tendency of stiffening than A-CXL protocols have, which was demonstrated by Scheimpflug-based tonometry and stress-strain extensometry.

Topics & Concepts

Basal cell carcinomaHedgehogHedgehog signaling pathwayBasal cellBasal (medicine)MedicineCancer researchInternal medicineBiologyCell biologySignal transductionInsulinHedgehog Signaling Pathway StudiesCancer and Skin LesionsNonmelanoma Skin Cancer Studies
Effective treatment of locally advanced periocular basal cell carcinoma with oral hedgehog pathway inhibitor? | Litcius